Thomas L Steinemann

Title: Thomas L. Steinemann: Innovator in Ophthalmology

Introduction

Thomas L. Steinemann is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of ophthalmology, particularly through his innovative patents. With a total of 2 patents, his work focuses on reducing intraocular fibrin and addressing various intraocular diseases.

Latest Patents

Steinemann's latest patents include groundbreaking methods for ophthalmologic uses of Protein C. The first patent provides a method of reducing intraocular fibrin by administering a pharmacologically effective dose of Protein C to individuals with elevated levels of intraocular fibrin. Additionally, this invention outlines various methods for preventing intraocular fibrin formation, treating intraocular diseases, and reducing intraocular inflammation. The second patent mirrors the first, emphasizing the importance of Protein C in ophthalmologic applications.

Career Highlights

Steinemann is affiliated with the University of Arkansas, where he continues to advance research in ophthalmology. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from intraocular conditions.

Collaborations

Some of his notable coworkers include Louis M. Fink and Ivory A. Reis, who have collaborated with him on various research projects.

Conclusion

Thomas L. Steinemann's contributions to ophthalmology through his innovative patents highlight his commitment to improving patient care. His work with Protein C represents a significant advancement in the treatment of intraocular diseases.